Hamburg: FDA is taking concerns over 510(k) changes seriously

10/21/2010 | (Boston)

The FDA is conducting a thorough review of the public comments and "substantive concerns" regarding its proposed changes to the 510(k) process for clearing medical devices, said Dr. Margaret Hamburg, the agency's chief. During her speech at a conference in Washington, D.C., Hamburg said the FDA will provide explanations before adopting a proposal that raised a number of significant concerns among the industry.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC